Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle- aged men

Metabolism: Clinical and Experimental

Volumn 47, Issue 9, 1998, Pages 1075-1082

  Dengel, Donald R ^a   Hagberg, James M ^d   Pratley, Richard E ^b   Rogus, Ellen M ^d   Goldberg, Andrew P ^c  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c BALTIMORE VA MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AEROBIC METABOLISM; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EXERCISE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SITTING; SYSTOLIC BLOOD PRESSURE;

EID: 0031722116     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90281-5     Document Type: Article

References (46)

1. Rowland M, Roberts J: Blood pressure levels and hypertension in persons aged 6-74 years, United States, 1976-80, NCHS Advance Data, No. 84. Washington, DC, Vital and Health Statistics of the National Center for Health Statistics, US DHHS, 1982
2. Sims EAH, Berchtold P: Obesity and hypertension; mechanism and implications for management. JAMA 247:49-52, 1982
3. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 153:154-183, 1993
4. DeFronzo RA, Ferrannini E: Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
5. Reaven GM: Relationship between insulin resistance and hypertension. Diabetes Care 14:33-38, 1991 (suppl 4)
6. Grimm RH, Flack JM, Grandits GA, et al: Long-term effects on plasma lipids of diet and drugs to treat hypertension. JAMA 275:1549-1556, 1996
7. Weinberger MH: Antihypertensive therapy and lipids: Evidence, mechanisms, and implications. Arch Intern Med 145:1102-119, 1985
8. Staessen J, Fagard R, Lijnen P, et al: Body weight, sodium intake and blood pressure. J Hypertens 7:19-23, 1989 (suppl 1)
9. Hagberg JM: Exercise, fitness, and hypertension, in Bouchard C, Shephard RJ, Stephens T, et al (eds): Exercise, Fitness, and Health. Champaign, IL Human Kinetics, 1990, pp 455-465
10. Despres J-P, Pouliot C, Moorjani S, et al: Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol 261:E159-E167, 1991
11. Schwartz RS: The independent effects of dietary WL and aerobic training on high density lipoproteins and apolipoprotein A-I concentrations in obese men. Metabolism 36:165-171, 1987
12. Wood PD, Stefanick ML, Williams PT, et al: The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med 325:461-466, 1991
13. Katzel LI, Bleecker ER, Colman EG, et al: Effects of weight loss vs. Aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial. JAMA 274:1915-1921, 1995
14. Nicklas B, Katzel LI, Busby-Whitehead J, et al: Increases in high-density lipoprotein cholesterol with endurance exercise training are blunted in obese compared with lean men. Metabolism 46:556-561, 1997
15. Lamarche B, Despres J-P, Pouliot C, et al: Is body fat loss a determinant factor in the improvement of carbohydrate and lipid metabolism following AEX in obese women? Metabolism 41:1249-1256, 1992
16. Katzel LI, Bleecker ER, Rogus E, Goldberg AP: Sequential effects of aerobic exercise training and weight loss on risk factors for coronary disease in healthy, obese middle-aged and older men. Metabolism 46:1441-1447, 1997
17. Dengel DR, Pratley RE, Hagberg JM, et al: Distinct effects of AEX training and WL on glucose homeostasis in obese sedentary men. J Appl Physiol 81:318-325, 1996
18. 1983 metropolitan height and weight tables. Stat Bull Metrop Life Found 64:3-9, 1983
19. Bruce RA, Hornsten TR: Exercise testing in the evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis 11:371-390, 1969
20. American Heart Association Steering Committee: Dietary Guidelines for Healthy American Adults. A Statement for Physicians and Health Professional by The Nutrition Committee of The American Heart Association. Circulation 77:721A-724A, 1988
21. Dengel DR, Pratley RE, Hagberg JM, et al: Impaired insulin sensitivity and maximal responsiveness in older hypertensive men. Hypertension 23:320-324, 1994
22. Siri WE: Body composition from fluid spaces and density: Analysis of methods, in Brozek J, Henschel A (eds): Techniques for Measuring Body Composition. Washington, DC, National Academy of Science, National Research Council, 1961, pp 223-244
23. Pratley RE, Coon PJ, Muller DC, et al: The effects of single and sequential insulin infusions on glucose disposal in older men. Exp Gerontol 28:381-391, 1993
24. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
25. McGuire EA, Tobin JD, Berman M, et al: Kinetics of native insulin in diabetic, obese and aged men. Diabetes 28:110-120, 1979
26. Kolterman OG, Insel J, Saekow M, et al: Mechanisms of insulin resistance in human obesity. Evidence for receptor and postreceptor defects. J Clin Invest 65:1272-1284, 1980
27. Rizza RA, Mandarino LJ, Gerich JE: Dose-response characteristics for the effect of insulin on production and utilization of glucose in man. Am J Physiol 240:E630-E639, 1981
28. Zaharko DS, Beck LV: Studies of a simplified plasma insulin immunoassay using cellulose powder. Diabetes 17:444-447, 1968
29. DeLean A, Munson PJ, Guardabasso V, et al: A User's Guide to Allfit. Bethesda, MD, National Institutes of Health, 1968
30. Allian CC, Poon L, Chan CS, et al: Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475, 1974
31. Simpson EJ, DeMers LM, Krieg AF: Faster enzymatic procedure for serum triglyceride. Clin Chem 21:470-475, 1975
32. 2+ precipitation. Clin Chem 28:1379-1388, 1982
33. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
34. Gidez LI, Miller GI, Burstein M, et al: Separation and quantification of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 23:1206-1223, 1982
35. Karvonen M, Kentala K, Musta O: The effects of training heart rate: a longitudinal study. Ann Med Exp Biol Fenn 35:307-315, 1957
36. World Health Organization: WHO Expert Committee on Diabetes Mellitus. World Health Organization Technical Report Series 646. Geneva, Switzerland, World Health Organization, 1980, pp 6-80
37. Zavaroni I, Bonora E, Pagliara M, et al: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706, 1989
38. Expert Panel in Detection, Evaluation and treatment of High Blood Cholesterol in Adults: Summary of the second report of the National Cholesterol Education Program (NCEP). JAMA 269:3015-3023, 1993
39. Kaplan N: Clinical Hypertension (ed 6). Baltimore, MD, Williams & Wilkins, 1994
40. Seals DR, Hagberg JM, Hurley BF, et al: Effects of endurance training on glucose tolerance and plasma lipid levels in older men and women. JAMA 252:645-649, 1984
41. Bogardus C, Ravussin E, Robbins DC, et al: Effects of physical training and diet therapy on carbohydrate metabolism in patients with glucose intolerance and non-insulin-dependent diabetes mellitus. Diabetes 33:311-318, 1984
42. Tonino RP: Effect of physical training on the insulin resistance of aging. Am J Physiol 256:E352-E356, 1989
43. Houmard JA, Egan PC, Neufer PD, et al: Elevated skeletal muscle glucose transporter levels in exercise-trained middle-aged men. Am J Physiol 261:E437-E443, 1991
44. Dela F, Mikines KJ, Larsen JJ, et al: Training-induced enhancement of insulin action in human skeletal muscle: The influence of aging. J Gerontol Biol Sci 51A:B247-B252, 1996
45. Nolan JJ, Ludvik B, Beerdsen P, et al: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188-1193, 1994
46. Diabetes Prevention Program (DPP): Diabetes Prevention Program Research Group. Diabetes 46:138A, 1997 (suppl 1, abstr)